← Russell 3000 cross-section

SHC Sotera Health Co

Trailing twelve months to 2026-06-30 · as filed 2026-08-06, not restated
Healthcare

Scale

Market cap
$5.6bn
Revenue TTM
$1.2bn
Net income TTM
$164m
Free cash flow
$113m
Composite score
Sector rank
#1009

Valuation

P / E
34.3
EV / EBITDA
EV / sales
6.1
FCF yield
2.01%
Earnings yield vs 10-yr
-1.82pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
13.4%
EBITDA margin
ROE
24.6%
ROIC
Revenue growth
8.2%

Insider activity, last 90 days

Net open-market
$-24.00m
Buyers
0
Sellers
2

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

For the definition of Adjusted Net Income and Adjusted EBITDA and the reconciliation of these non-GAAP measures from net income (loss), please see “Non-GAAP Financial Measures.” CONSOLIDATED RESULTS OF OPERATIONS Three Months Ended June 30, 2026 as compared to Three Months Ended June 30, 2025 The following table sets forth the components of our results of operations for the three months ended June 30, 2026 and 2025: (a) Adjusted Net Income and Adjusted EBITDA are non-GAAP financial measures. Net revenues were $321.4 million for the three months ended June 30, 2026, an increase of $27.0 million, or 9.2%, as compared to the three months ended June 30, 2025. …Sotera Health Co, 10-Q, period ended 2026-06-30, filed 2026-08-06

Read the full passage →